Clinical Trials · NCT01473147
Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Chang Gung Memorial Hospital
- Enrollment
- 51
- Start date
- Oct 2011
- Locations
- 1 site, Taiwan
- Primary endpoint
- Mean amplitude of glycaemic excursions (MAGE)